Annual Total Long Term Liabilities
$6.17 M
-$11.45 M-64.98%
31 December 2023
Summary:
Catalyst Pharmaceuticals annual total long term liabilities is currently $6.17 million, with the most recent change of -$11.45 million (-64.98%) on 31 December 2023. During the last 3 years, it has risen by +$6.17 million (+100.00%). CPRX annual total long term liabilities is now -64.98% below its all-time high of $17.62 million, reached on 31 December 2022.CPRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$5.67 M
+$287.00 K+5.33%
30 September 2024
Summary:
Catalyst Pharmaceuticals quarterly total long term liabilities is currently $5.67 million, with the most recent change of +$287.00 thousand (+5.33%) on 30 September 2024. Over the past year, it has dropped by -$1.18 million (-17.25%). CPRX quarterly long term liabilities is now -69.15% below its all-time high of $18.39 million, reached on 30 September 2022.CPRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPRX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.0% | -17.3% |
| 3 y3 years | +100.0% | +42.8% |
| 5 y5 years | +3885.8% | +681.9% |
CPRX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.0% | -69.2% | +52.2% | |
| 5 y | 5 years | -65.0% | -69.2% | ||
| alltime | all time | -65.0% | -69.2% |
Catalyst Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.67 M(+5.3%) |
| June 2024 | - | $5.39 M(-5.5%) |
| Mar 2024 | - | $5.70 M(-7.6%) |
| Dec 2023 | $6.17 M(-65.0%) | $6.17 M(-10.0%) |
| Sept 2023 | - | $6.86 M(-57.4%) |
| June 2023 | - | $16.10 M(-4.5%) |
| Mar 2023 | - | $16.86 M(-4.3%) |
| Dec 2022 | $17.62 M(+352.5%) | $17.62 M(-4.2%) |
| Sept 2022 | - | $18.39 M(+393.2%) |
| June 2022 | - | $3.73 M(-2.2%) |
| Mar 2022 | - | $3.81 M(-2.1%) |
| Dec 2021 | $3.89 M(>+9900.0%) | $3.89 M(-2.0%) |
| Sept 2021 | - | $3.97 M(-1.9%) |
| June 2021 | - | $4.05 M(-1.9%) |
| Mar 2021 | - | $4.13 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| June 2020 | - | $0.00(-100.0%) |
| Mar 2020 | - | $568.40 K(-12.2%) |
| Dec 2019 | $647.50 K(+318.3%) | $647.50 K(-10.8%) |
| Sept 2019 | - | $725.70 K(-9.4%) |
| June 2019 | - | $801.30 K(-8.4%) |
| Mar 2019 | - | $875.10 K(+465.3%) |
| Dec 2018 | $154.80 K(-1.7%) | $154.80 K(-6.1%) |
| Sept 2018 | - | $164.80 K(+15.0%) |
| June 2018 | - | $143.30 K(-4.7%) |
| Mar 2018 | - | $150.40 K(-4.5%) |
| Dec 2017 | $157.50 K(-48.1%) | $157.50 K(-4.3%) |
| Sept 2017 | - | $164.50 K(-3.5%) |
| June 2017 | - | $170.50 K(-75.5%) |
| Mar 2017 | - | $695.50 K(+129.2%) |
| Dec 2016 | $303.40 K | $303.40 K(-26.8%) |
| Sept 2016 | - | $414.30 K(+33.5%) |
| June 2016 | - | $310.30 K(-33.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $465.50 K(-60.7%) |
| Dec 2015 | $1.18 M(-57.9%) | $1.18 M(-22.4%) |
| Sept 2015 | - | $1.53 M(-49.0%) |
| June 2015 | - | $2.99 M(-16.4%) |
| Mar 2015 | - | $3.58 M(+27.3%) |
| Dec 2014 | $2.81 M(+52.9%) | $2.81 M(-14.4%) |
| Sept 2014 | - | $3.28 M(+38.1%) |
| June 2014 | - | $2.38 M(+10.3%) |
| Mar 2014 | - | $2.15 M(+17.2%) |
| Dec 2013 | $1.84 M(+253.3%) | $1.84 M(-48.4%) |
| Sept 2013 | - | $3.56 M(+235.2%) |
| June 2013 | - | $1.06 M(+88.1%) |
| Mar 2013 | - | $565.20 K(+8.6%) |
| Dec 2012 | $520.50 K(-68.5%) | $520.50 K(-73.4%) |
| Sept 2012 | - | $1.96 M(+217.6%) |
| June 2012 | - | $616.10 K(-55.8%) |
| Mar 2012 | - | $1.39 M(-15.8%) |
| Dec 2011 | $1.65 M(>+9900.0%) | $1.65 M(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $10.70 K(-27.2%) |
| Dec 2010 | $14.70 K(-73.0%) | $14.70 K(-21.8%) |
| Sept 2010 | - | $18.80 K(-60.3%) |
| June 2010 | - | $47.40 K(+1.3%) |
| Mar 2010 | - | $46.80 K(-14.0%) |
| Dec 2009 | $54.40 K(+27.7%) | $54.40 K(+9.7%) |
| Sept 2009 | - | $49.60 K(+36.3%) |
| June 2009 | - | $36.40 K(-7.8%) |
| Mar 2009 | - | $39.50 K(-7.3%) |
| Dec 2008 | $42.60 K(-21.0%) | $42.60 K(-6.8%) |
| Sept 2008 | - | $45.70 K(-6.2%) |
| June 2008 | - | $48.70 K(-4.7%) |
| Mar 2008 | - | $51.10 K(-5.2%) |
| Dec 2007 | $53.90 K | $53.90 K |
FAQ
- What is Catalyst Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Catalyst Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CPRX is $6.17 M
What is the all time high annual total long term liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total long term liabilities is $17.62 M
What is Catalyst Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CPRX annual total long term liabilities has changed by -$11.45 M (-64.98%)
What is Catalyst Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CPRX is $5.67 M
What is the all time high quarterly long term liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total long term liabilities is $18.39 M
What is Catalyst Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CPRX quarterly total long term liabilities has changed by -$1.18 M (-17.25%)